Etoricoxib + Thiocolchicoside Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 60mg +4mg
Reference Brands: Etoford-MR
Category:
Analgesic
Etoricoxib + Thiocolchicoside is a combination of two medicines: Etoricoxib and Thiocolchicoside, which relieves pain and relaxes the muscles. Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) which works by blocking the release of certain chemical messengers that cause pain and inflammation (redness and swelling). Thiocolchicoside is a muscle relaxant. It works on the centers in the brain and spinal cord to relieve muscle stiffness or spasm and to improve pain and movement of muscles.
Etoricoxib + Thiocolchicoside Tablet is available in Tablets
and strengths such as 60mg +4mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Etoricoxib + Thiocolchicoside Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Etoricoxib + Thiocolchicoside Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Etoricoxib + Thiocolchicoside tablets are regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in accordance with GMP and MDR standards. In the US, approval involves validation, safety assessments, and GMP compliance; however, fixed-dose combinations are mainly used in compounded formulations. In the EU, CE marking certifies conformity with MDR standards, with some formulations approved for musculoskeletal conditions. These products undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective combination therapies worldwide supporting pain and spasm management.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing